AIM
ATRC icon

Aigen Investment Management’s AtriCure ATRC Stock Holding History

Aigen Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,136
Closed -$255K – 670
2023
Q4 		$255K Buy
7,136
+1,383
+24% +$51.4K 0.05% 554
2023
Q3 		$252K Sell
5,753
-547
-9% -$26.7K 0.05% 584
2023
Q2 		$311K Sell
6,300
-7,345
-54% -$339K 0.05% 486
2023
Q1 		$566K Buy
+13,645
New +$566K 0.08% 288
2020
Q2 		– Sell
-397
Closed -$13K – 826
2020
Q1 		$13K Buy
+397
New +$14.3K ﹤0.01% 1131

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aigen Investment Management's ATRC Position: Q1 2024 in Review

Aigen Investment Management sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 7,136 shares — an estimated $255K sold.

Aigen Investment Management first reported a position in ATRC in Q1 2020 and held it in 5 quarters. The position peaked at $566K in Q1 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • Aigen Investment Management reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 7,136 AtriCure shares in Q1 2024, an estimated $255K.
  • Aigen Investment Management first reported a position in AtriCure in Q1 2020 and held it in 5 quarters.
  • Aigen Investment Management's AtriCure position peaked at $566K in Q1 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.